Estonia-based Better Medicine raises nearly $7 million to expand its radiology AI solution and enter the U.S. market.
Key Details
- 1Better Medicine is an AI startup focused on radiology, founded in 2020 in Estonia.
- 2The company raised an additional $1.2 million, bringing total funding close to $7 million.
- 3Its flagship product, BMVision Kidney, detects malignant lesions from CT scans.
- 4Better Medicine currently operates in six countries and aims to expand to the U.S.
- 5The new funding will support further European growth and preparations for U.S. market entry.
Why It Matters
Better Medicine's growth and international expansion reflect ongoing investor confidence in radiology AI. Tools that integrate into radiologist workflows and target specific organs, such as the kidney, could enhance cancer detection and address radiologist shortages globally.
Source
Radiology Business
Related News
•AuntMinnie
Toronto Study: LLMs Must Cite Sources for Radiology Decision Support
University of Toronto researchers found that large language models (LLMs) such as DeepSeek V3 and GPT-4o offer promising support for radiology decision-making in pancreatic cancer when their recommendations cite guideline sources.
•AI in Healthcare
Nvidia, Amazon Drive AI Expansion Across Genomics and Radiology
Major healthcare and technology companies partner to push AI advancements in genomics, radiology, and broader healthcare.
•Radiology Business
AI Model Uses CT Scans to Reveal Biomarker for Chronic Stress
Researchers developed an AI model to measure chronic stress using adrenal gland volume on routine CT scans.